Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Alignment Health CEO John Kao is bullish about the company's continued growth, reiterating to investors that its strong revenue and membership gains in the first quarter would continue in Q2 despit | Alignment Health CEO John Kao reiterated Tuesday that the company's strong revenue and membership growth in the first quarter would continue in Q2 despite the Medicare Advantage headwinds confronting many other insurers.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

Alignment Healthcare delivered a strong second quarter, in what CEO John Kao said was supported by the deployment of its new…

Major health insurers saw positive signs in the second quarter, but the pressures they've faced over the past year haven't…

Universal Health Services notched a solid second quarter and has raised its revenue guidance for the year, though it now expects…

Clover Health's Medicare Advantage membership grew 48% year-over-year in the second quarter at 157,309 members, as executives…

The health insurance industry weathered a rough 2025, and the turnaround for some companies through the midpoint has surprised…

Alignment Healthcare reported its second consecutive profitable quarter in part by managing medical expenses better than many of…